Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE283335 | GEO | 2024/12/26

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [xenograft]

Project description:Heterogeneity between patients poses a significant challenge in cancer drug development. Although success of a drug candidate in the clinic depends on efficacy across large numbers of diverse patients, only a few in vivo preclinical models are used for assaying a preclinical drug candidate due to the lack of scalability of traditional xenograft models. To address this limitation, we developed GENEVA, a scalable platform that enables the measurement of molecular and phenotypic responses to drug perturbations at single-cell resolution, both in 3D and in vivo. GENEVA models the genetic diversity of cancer by combining multiple patient-derived cell lines and cancer cell lines into pooled 3D cultures and xenograft models, allowing us to study drug responses across a wide range of genetic backgrounds within a single experiment. This platform integrates high-resolution transcriptomics with multiplexed single-cell profiling, providing a unique ability to uncover the interplay between cancer genotypes and drug responses. In this study, we apply GENEVA to investigate KRAS G12C inhibitors and demonstrate that mitochondrial activation is a key driver of cell death following KRAS inhibition. Additionally, we identify epithelial to mesenchymal transition (EMT) as a prominent resistance mechanism to KRAS G12C inhibition using in vivo GENEVA mice. These findings highlight the utility of GENEVA in identifying novel therapeutic targets and optimizing combination therapies, while underscoring its potential to bridge the gap between preclinical cancer models and patient outcomes by modeling the complexity of tumor heterogeneity in a scalable and robust assay.

2025-12-02 | GSE311813 | GEO

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [scRNA-seq]

2025-12-02 | GSE311811 | GEO

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [CRISPR screen]

2025-12-02 | GSE311810 | GEO

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [11 cancer cell lines]

2024-12-26 | GSE282350 | GEO

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [8 cancer cell lines]

2024-12-26 | GSE283141 | GEO

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations

Project description:Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations

| PRJNA1193214 | ENA

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [xenograft]

Project description:Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [xenograft]

| PRJNA1370945 | ENA

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [CRISPR screen]

Project description:Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [CRISPR screen]

| PRJNA1370940 | ENA

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [scRNA-seq]

Project description:Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [scRNA-seq]

| PRJNA1370939 | ENA

Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [11 cancer cell lines]

Project description:Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations [11 cancer cell lines]

| PRJNA1188170 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data